Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
1. 系统已在2025-05-19 15:39:56对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1158/1078-0432.CCR-22-2630
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Krista Kinneer; Philipp Wortmann; Zachary A. Cooper; Niall J. Dickinson; Luke Masterson; Thais Cailleau; Ian Hutchinson; Balakumar Vijayakrishnan; Mary McFarlane; Kathryn Ball; Michael Davies; Arthur Lewis; Yue Huang; Anton I. Rosenbaum; Jiaqi Yuan; Jon Chesebrough; Judith Anderton; Noel Monks; Steven Novick; Jixin Wang; Nazzareno Dimasi; R. James Christie; Darrin Sabol; Frances Anne Tosto; Yann Wallez; Elisabetta Leo; Mark R. Albertella; Anna D. Staniszewska; David A. Tice; Philip W. Howard; Nadia Luheshi; Puja Sapra
全文下载地址: https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-22-2630/3222102/ccr-22-2630.pdf
